Finally, we also evaluated whether the percentage of CD20+ T cells, and their distribution among the CD4+ and CD8+ T cell populations, varied according to the IGHV mutational status of both HC-MBL and CLL (Figure 11). The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.